Abstract
Cavernous cerebral malformations (CCMs) are a well-defined epilepsy-associated pathology. They represent lesions/conglomerates of abnormally configured vessels leading to seizures either as a result of physiological changes affecting the cerebral cortex immediately surrounding the CCM (an epileptogenic mechanism that is relevant for both temporal and extratemporal lesions), or as a result of promoting epileptogenicity in remote but anatomo-functionally connected brain regions (a mechanism that is particularly relevant for temporal lobe lesions). This review details the pathological findings in CCMs and discusses the mechanisms of epileptogenicity in this context. The bulk of the review will focus on therapeutic strategies. Medical therapy using antiepileptic drugs is recommended as a first-line therapy, but surgical removal of the CCM with the surrounding cortex should be pursued if seizures prove to be drug resistant. Early timing of the resection and complete removal of any associated epileptic pathology are critical for best outcomes. In addition to reviewing the available data from prior series, we present original research from two specialized epilepsy centers targeted at answering particularly pressing clinical questions mainly related to the ideal timing and extent of surgery. Further research is needed to define the best surgical strategies in patients with temporal lobe CCMs and structurally normal hippocampi.
Similar content being viewed by others
References
Amin-Hanjani S, Robertson R, Arginteanu MS, Scott RM (1998) Familial intracranial arteriovenous malformations. Case report and review of the literature. Pediatr Neurosurg 29:208–213
Awad I, Jabbour P (2006) Cerebral cavernous malformations and epilepsy. Neurosurg Focus 21:e7
Bacigaluppi S, Retta SF, Pileggi S, Fontanella M, Goitre L, Tassi L, La Camera A, Citterio A, Patrosso MC, Tredici G, Penco S (2013) Genetic and cellular basis of cerebral cavernous malformations: implications for clinical management. Clin Genet 83:7–14. doi:10.1111/j.1399-0004.2012.01892.x
Baumann CR, Schuknecht B, Lo Russo G, Cossu M, Citterio A, Andermann F, Siegel AM (2006) Seizure outcome after resection of cavernous malformations is better when surrounding hemosiderin-stained brain also is removed. Epilepsia 47:563–566. doi:10.1111/j.1528-1167.2006.00468.x
Baumann CR, Acciarri N, Bertalanffy H, Devinsky O, Elger CE, Lo Russo G, Cossu M, Sure U, Singh A, Stefan H, Hammen T, Georgiadis D, Baumgartner RW, Andermann F, Siegel AM (2007) Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patients. Epilepsia 48:559–563. doi:10.1111/j.1528-1167.2006.00941.x
Ben-Ari Y, Dudek FE (2010) Primary and secondary mechanisms of epileptogenesis in the temporal lobe: there is a before and an after. Epilepsy Curr 10:118–125. doi:10.1111/j.1535-7511.2010.01376.x
Blumcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, Palmini A, Jacques TS, Avanzini G, Barkovich AJ, Battaglia G, Becker A, Cepeda C, Cendes F, Colombo N, Crino P, Cross JH, Delalande O, Dubeau F, Duncan J, Guerrini R, Kahane P, Mathern G, Najm I, Ozkara C, Raybaud C, Represa A, Roper SN, Salamon N, Schulze-Bonhage A, Tassi L, Vezzani A, Spreafico R (2011) The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 52:158–174. doi:10.1111/j.1528-1167.2010.02777.x
Cappabianca P, Alfieri A, Maiuri F, Mariniello G, Cirillo S, de Divitiis E (1997) Supratentorial cavernous malformations and epilepsy: seizure outcome after lesionectomy on a series of 35 patients. Clin Neurol Neurosurg 99:179–183
Chassoux F, Landre E, Mellerio C, Laschet J, Devaux B, Daumas-Duport C (2013) Dysembryoplastic neuroepithelial tumors: epileptogenicity related to histologic subtypes. Clin Neurophysiol 124:1068–1078. doi:10.1016/j.clinph.2012.11.015
Churchyard A, Khangure M, Grainger K (1992) Cerebral cavernous angioma: a potentially benign condition? Successful treatment in 16 cases. J Neurol Neurosurg Psychiatry 55:1040–1045
Cohen DS, Zubay GP, Goodman RR (1995) Seizure outcome after lesionectomy for cavernous malformations. J Neurosurg 83:237–242. doi:10.3171/jns.1995.83.2.0237
Del Curling O, Kelly DL Jr, Elster AD, Craven TE (1991) An analysis of the natural history of cavernous angiomas. J Neurosurg 75:702–708. doi:10.3171/jns.1991.75.5.0702
Dube C, da Silva Fernandes MJ, Nehlig A (2001) Age-dependent consequences of seizures and the development of temporal lobe epilepsy in the rat. Dev Neurosci 23:219–223 Doi:46147
Englot DJ, Han SJ, Lawton MT, Chang EF (2011) Predictors of seizure freedom in the surgical treatment of supratentorial cavernous malformations. J Neurosurg 115:1169–1174. doi:10.3171/2011.7.JNS11536
Fauser S, Schulze-Bonhage A (2006) Epileptogenicity of cortical dysplasia in temporal lobe dual pathology: an electrophysiological study with invasive recordings. Brain 129:82–95 awh687 [pii]
Fernandez S, Miro J, Falip M, Coello A, Plans G, Castaner S, Acebes JJ (2012) Surgical versus conservative treatment in patients with cerebral cavernomas and non refractory epilepsy. Seizure 21:785–788. doi:10.1016/j.seizure.2012.09.004
Ferrer I, Ferrer I, Kaste M, Kalimo H (2008) Vascular diseases. In: Love S, Louis DN, Ellison DW (eds) Greenfield’s Neuropathology, vol 1. Edward Arnold, London, pp 121–240
Ferrier CH, Aronica E, Leijten FS, Spliet WG, Boer K, van Rijen PC, van Huffelen AC (2007) Electrocorticography discharge patterns in patients with a cavernous hemangioma and pharmacoresistent epilepsy. J Neurosurg 107:495–503. doi:10.3171/JNS-07/09/0495
Ferroli P, Casazza M, Marras C, Mendola C, Franzini A, Broggi G (2006) Cerebral cavernomas and seizures: a retrospective study on 163 patients who underwent pure lesionectomy. Neurol Sci 26:390–394. doi:10.1007/s10072-006-0521-2
Hammen T, Romstock J, Dorfler A, Kerling F, Buchfelder M, Stefan H (2007) Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: a study in patients with cavernous haemangiomas associated with symptomatic epilepsy. Seizure 16:248–253. doi:10.1016/j.seizure.2007.01.001
Hauser WA, Mohr JP (2011) Seizures, epilepsy, and vascular malformations. Neurology 76:1540–1541. doi:10.1212/WNL.0b013e318219fb97
Janszky J, Janszky I, Schulz R, Hoppe M, Behne F, Pannek HW, Ebner A (2005) Temporal lobe epilepsy with hippocampal sclerosis: predictors for long-term surgical outcome. Brain 128:395–404. doi:10.1093/brain/awh358
Jeong SW, Lee SK, Hong KS, Kim KK, Chung CK, Kim H (2005) Prognostic factors for the surgery for mesial temporal lobe epilepsy: longitudinal analysis. Epilepsia 46:1273–1279. doi:10.1111/j.1528-1167.2005.33504.x
Josephson CB, Leach JP, Duncan R, Roberts RC, Counsell CE, Al-Shahi Salman R, Scottish Audit of Intracranial Vascular Malformations (SAIVMs) Steering Committee and Collaborators (2011) Seizure risk from cavernous or arteriovenous malformations: prospective population-based study. Neurology 76:1548–1554. doi:10.1212/WNL.0b013e3182190f37
Luders HO (2001) Clinical evidence for secondary epileptogenesis. Int Rev Neurobiol 45:469–480
McIntosh AM, Kalnins RM, Mitchell LA, Fabinyi GC, Briellmann RS, Berkovic SF (2004) Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrence. Brain 127:2018–2030. doi:10.1093/brain/awh221
Menzler K, Chen X, Thiel P, Iwinska-Zelder J, Miller D, Reuss A, Hamer HM, Reis J, Pagenstecher A, Knake S, Bertalanffy H, Rosenow F, Sure U (2010) Epileptogenicity of cavernomas depends on (archi-) cortical localization. Neurosurgery 67:918–924. doi:10.1227/NEU.0b013e3181eb5032
Moriarity JL, Wetzel M, Clatterbuck RE, Javedan S, Sheppard JM, Hoenig-Rigamonti K, Crone NE, Breiter SN, Lee RR, Rigamonti D (1999) The natural history of cavernous malformations: a prospective study of 68 patients. Neurosurgery 44:1166–1171 discussion 1172-3
Morrell F (1989) Varieties of human secondary epileptogenesis. J Clin Neurophysiol 6:227–275
Morrell F (1985) Secondary epileptogenesis in man. Arch Neurol 42:318–335
Morrell F, deToledo-Morrell L (1999) From mirror focus to secondary epileptogenesis in man: an historical review. Adv Neurol 81:11–23
Riant F, Bergametti F, Ayrignac X, Boulday G, Tournier-Lasserve E (2010) Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. FEBS J 277:1070–1075. doi:10.1111/j.1742-4658.2009.07535.x
Rosenow F, Alonso-Vanegas MA, Baumgartner C, Blumcke I, Carreno M, Gizewski ER, Hamer HM, Knake S, Kahane P, Luders HO, Mathern GW, Menzler K, Miller J, Otsuki T, Ozkara C, Pitkanen A, Roper SN, Sakamoto AC, Sure U, Walker MC, Steinhoff BJ, Surgical Task Force, Commission on Therapeutic Strategies of the ILAE (2013) Cavernoma-related epilepsy: review and recommendations for management––report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 54:2025–2035. doi:10.1111/epi.12402
Simasathien T, Vadera S, Najm I, Gupta A, Bingaman W, Jehi L (2013) Improved outcomes with earlier surgery for intractable frontal lobe epilepsy. Ann Neurol 73:646–654. doi:10.1002/ana.23862
Sommer B, Kasper BS, Coras R, Blumcke I, Hamer HM, Buchfelder M, Roessler K (2013) Surgical management of epilepsy due to cerebral cavernomas using neuronavigation and intraoperative MR imaging. Neurol Res 35:1076–1083. doi:10.1179/016164113X13801151880551
Stavrou I, Baumgartner C, Frischer JM, Trattnig S, Knosp E (2008) Long-term seizure control after resection of supratentorial cavernomas: a retrospective single-center study in 53 patients. Neurosurgery 63:888–896. doi:10.1227/01.NEU.0000327881.72964.6E discussion 897
Surges R, Schulze-Bonhage A, Altenmuller DM (2008) Hippocampal involvement in secondarily generalised seizures of extrahippocampal origin. J Neurol Neurosurg Psychiatry 79:924–929 (pii): jnnp.2007.129387
von der Brelie C, Schramm J (2011) Cerebral cavernous malformations and intractable epilepsy: the limited usefulness of current literature. Acta Neurochir (Wien) 153:249–259. doi:10.1007/s00701-010-0915-z
von der Brelie C, Malter MP, Niehusmann P, Elger CE, von Lehe M, Schramm J (2013) Surgical management and long-term seizure outcome after epilepsy surgery for different types of epilepsy associated with cerebral cavernous malformations. Epilepsia 54:1699–1706. doi:10.1111/epi.12327
Williamson A, Patrylo PR, Lee S, Spencer DD (2003) Physiology of human cortical neurons adjacent to cavernous malformations and tumors. Epilepsia 44:1413–1419
Yeon JY, Kim JS, Choi SJ, Seo DW, Hong SB, Hong SC (2009) Supratentorial cavernous angiomas presenting with seizures: surgical outcomes in 60 consecutive patients. Seizure 18:14–20. doi:10.1016/j.seizure.2008.05.010
Zevgaridis D, van Velthoven V, Ebeling U, Reulen HJ (1996) Seizure control following surgery in supratentorial cavernous malformations: a retrospective study in 77 patients. Acta Neurochir (Wien) 138:672–677
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jehi, L.E., Palmini, A., Aryal, U. et al. Cerebral cavernous malformations in the setting of focal epilepsies: pathological findings, clinical characteristics, and surgical treatment principles. Acta Neuropathol 128, 55–65 (2014). https://doi.org/10.1007/s00401-014-1294-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-014-1294-y